PRD Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D
PRD Therapeutics is a clinical-stage company developing First-in-class orally available small molecule compounds PRD001 for the treatment of lipid metabolic diseases such as HoFH (Rare disease) and MASH/MASLD (NASH/NAFLD).